12 Reasons Why Trump May Be Losing The Plot
Photo Illustration by Thomas Levinson/The Daily Beast/Getty He spoke about people being forced to flee “South Africa” due to communism, when he meant to say “South America.” He recalled getting “indicted” over allegations he improperly sought help from Ukraine, when in reality he was “impeached.” And he was caught on camera appearing to nod off […]
The Surprising New Side Effect Of Taking GLP-1 Medications
Post Content
AirSculpt outlines $153M 2025 revenue outlook as company targets GLP-1-driven growth and margin improvement
Post Content
REMODELing Mechanistic Trials for Kidney Disease: a multi-modal, tissue-centered approach to understand the renal mechanism of action of semaglutide
Chronic kidney disease (CKD) poses a major global health burden and is one of the most common complications of type 2 diabetes (T2D). Drug trials have demonstrated that treatments, including sodium-glucose cotransporter-2 inhibitors, a glucagon-like peptide-1 (GLP-1) receptor agonist and a non-steroidal mineralocorticoid receptor antagonist, mitigate CKD progression, but the underlying nephroprotective mechanisms-of-action (MoA) remain […]
‘Do you take any of this stuff, Howard?’ Trump roasts his cabinet about their weight while announcing blockbuster Medicare Ozempic deal
President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy. Known as GLP-1 receptor agonists, the drugs have soared in popularity in recent years, but patient access has been a consistent problem because of their cost — around $500 […]
Hims & Hers Expands AI-Driven Personalized and Subscription-Based Care
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, has built a business model centered on personalized, subscription-based care that prioritizes convenience, accessibility and affordability. It offers recurring treatment plans for a wide range of conditions — from dermatology and mental health to sexual wellness and weight management — through its digital […]
Engineered probiotic restores GLP-1 signaling to ameliorate fiber-deficiency exacerbated colitis
Science Advances, Volume 11, Issue 45, November 2025.
Open Season starts Monday and feds face rising premiums and tough choices on coverage
Interview transcript: Terry Gerton: Open Season kicks off today. People might have been a little distracted by all the other things that are happening in the federal government and with the federal workforce, but if they wake up this morning and they’re listening to us, they go, ‘Oh my goodness, it’s Open Season.’ What should […]
Pfizer Discusses Drug Pricing Deal, Metsera Buyout Dispute on Q3 Call
On its third-quarter conference call held on Nov. 4, Pfizer PFE shed light on the two topics for which it has been in the news lately — the drug pricing deal with the Trump administration and the battle with Novo Nordisk NVO related to the Metsera MTSR buyout. Pfizer’s Metsera Buyout in Jeopardy? Pfizer is locked […]
Questions swirl after Trump’s GLP-1 pricing deal announcement
At a White House event Thursday, President Trump announced deals with drug makers Novo Nordisk and Eli Lilly to offer their popular GLP-1 obesity and diabetes drugs at lower prices for some Americans, namely some on Medicare and Medicaid plans. But questions linger about the significance of the deal. According to the announcement, Medicare and […]